Former Laureates
The Scheele Award Laureate 2021
Professor Craig Crews, Yale University “for his broad excellence in drug discovery and development, spanning from molecule to patient. He has combined groundbreaking science with strong entrepreneurship and received wide international recognition for his work on pharmacological modulation of protein turnover. His findings have led to new therapeutic approaches including the development of novel proteasome inhibitors and the PROTAC technology.”
The Scheele Award Laureate 2019
Professor Emmanuelle Charpentier, Max Planck Institute, Germany “Professor Emanuelle Charpentier has been awarded the Scheele prize 2019 for deciphering the molecular mechanisms of the CRISPR/Cas9 system – a gene editing tool with multiple applications in drug discovery and development” Read more about Professor Charpentier and her research here.
The Scheele Award Laureate 2017
Professor Charles L Sawyers, Memorial Sloan Ketterering Cancer Center NY, USA “for his outstanding contributions in life sciences. Professor Sawyers’ work has provided insights on the molecular mechanisms causing tumour drug resistance which has paved the way to new effective cancer treatments saving the lives of many patients.” Read more about Professor Sawyers and his research here.
Scheele Award Laureates 1961-
Later Nobel Laureates are underlined
2019 | Prof Emmanuelle Charpentier “For deciphering the molecular mechanisms of the CRISPR/Cas9 system – a gene editing tool with multiple applications in drug discovery and development” |
Max Planck Unit for the Science of Pathogens | Germany |
2017 | Prof Charles L Sawyers “For his outstanding contributions in life sciences. Professor Sawyers’ work has provided insights on the molecular mechanisms causing tumour drug resistance which has paved the way to new effective cancer treatments saving the lives of many patients” |
Memorial Sloan Ketterereing Cancer Center | USA |
2015 | Prof Robert S Langer | MIT | USA |
2013 | Prof Garret A FitzGerald | University of Pennsylvania | USA |
2011 | Prof Kathleen M Giacomini | University of California, San Fransisco | USA |
2009 | Prof Dennis J Slamon | Universitu of California, Los Angeles | USA |
2007 | Prof Mathias Uhlén | Royal Institute of Technology | Sweden |
2005 | Prof Jan van der Greef “In view of his outstandning and visionary contributions in the field of pharmaceutical and biomedical analysis” |
Leiden University | NL |
2003 | Prof Johathan A Ellman “in view of his outstandning contributions and pioneering work in the interface between combinatorial and medicinal chemistry” |
University of California, Berkley | USA |
2001 | Prof Andrew H Wyllie “In view of his outstandning contributions in the field of apoptosis” |
University of Cambridge | UK |
2000 | Prof Douwe D Breimer “In view of his outstandning contributions in the field of pharmaceutical science at large and pioneer reserach in pharmacokinetics and pharmacodynamics.” |
Leiden University | NL |
1999 | Prof John W Daly “In view of his outstandning contributions in the field of natural product chemistry at large and his special skills and insights centereda round the concept of bioactive natural products as lead compounds and as pharmacological tools in drug discovery.” |
National Institute of Health | USA |
1998 | Prof Albert I Wertheimer | Merck & Co Inc | USA |
1997 | Prof Julian E Davies | University of British Columbia | Canada |
1996 | Prof Gordon L Amidon | University of Michigan | USA |
1995 | Prof Patrick J Hendra | University of Southampton | UK |
1994 | Prof Gregory P Winter | Univeristy of Cambridge | UK |
1993 | Prof Alexander T Florence | University of London | UK |
1992 | Prof Koji Nakanishi | Suntory Institute | Japan |
1991 | Prof K Barry Sharpless | Massachusetts Institute of Technology | USA |
1990 | Prof Gerhard Levy | State University Of New York at Buffalo | USA |
1989 | Prof Dennis V Parke | University of Surrey | UK |
1988 | Prof David V Goeddel | Genenteck Inc | USA |
1987 | Prof Roland W Frei | Free University of Amsterdam | NL |
1986 | Prof Luc Montagnier | Institute of Pasteur | France |
1985 | Prof Stanley S Davis | University of Nottingham | UK |
1984 | Prof Malcolm Rowland | University of Manchester | UK |
1983 | Sir James W Black | Wellcome Research Labs | UK |
1982 | Prof Charles Weissmann | University of Zürich | Switzerland |
1981 | Prof George J Aghajanian | Yale University | USA |
1980 | Prof Harri R Nevanlinna | Blood Service of the Finnish Red Cross | Finland |
1979 | Prof Peter Speiser | ETH, Zürich | Switzerland |
1978 | Prof Sidney Riegelman | University of California | USA |
1977 | Prof Hans W Kosterlitz | University of Aberdeen | UK |
1976 | Prof Evan C Horning | Texas Medical Center | USA |
1975 | Prof Edward P Abraham | Oxford University | UK |
1974 | Prof E J Ariëns | University of Nijmegen | NL |
1973 | Prof Harold N MacFarland | Bio Research Lab Ltd | Canada |
1972 | Prof Carl Djerassi | Stanford University | USA |
1971 | Dr Albert Hofmann | Sandoz | Switzerland |
1970 | Dr Norman J Harper | Winthrop Labs | UK |
1969 | Prof Takeru Higuchi | University of Kansas | USA |
1968 | Prof Arnold H Beckett | Chelsea College of Science and Technology | UK |
1967 | Prof Bernard B Brodie | National Institute of Health | USA |
1965 | Dr Paul Janssen | Janssen Pharmaceutica | Belgium |
1964 | Dr Lewis H Sarett | Merck Sharp & Dhome | USA |
1963 | Prof Robert Schwyzer | CIBA | Switzerland |
1962 | Dr Frank P Doyle | Beecham Research Labs | UK |
1961 | Dr Frank L Rose | ICI | UK |
Professor Craig Crews
Professor Emmanuelle Charpentier
Professor Charles L Sawyers
Contact
Swedish Pharmaceutical Society
Wallingatan 26A,?111 81 Stockholm
Sweden
+46-(0)8 723 50 00
www.apotekarsocieteten.se